1.Oxytocin and Oxytocin Antagonist Metabolism in the Plasma of Pregnant Women.
Tae Hun AN ; Sok Cheon PAK ; Tae Gyu AHN
Korean Journal of Obstetrics and Gynecology 2002;45(6):921-925
OBJECTIVE: Oxytocin antagonists maybe useful in inhibiting the uterine contractions of preterm labor. One such compound is TT-235. The purpose of this study was to compare the resistance of TT-235 and oxytocin to enzymatic degradation by oxytocinase in pregnant human. METHODS: Blood samples from pregnant women not in labor were incubated in vitro with known amounts of oxytocin and TT-235. Samples were collected at 0, 15, 30, 45 and 60 minute intervals for oxytocin analysis and at 0, 10, 60 and 360 minutes for TT-235 analysis. Oxytocin was analyzed by radioimmunoassay after extraction while TT-235 was analyzed by radioreceptor assay. RESULTS: In human blood, oxytocin was readily metabolized with greater than 83% disappearance over the 60 minute incubation period. In contrast, TT-235 was stable up to 360 minutes of incubation. CONCLUSION: This study suggests that: (1) blood from pregnant human does contain oxytocinase at least in vitro; and (2) TT-235 was resistant to enzymatic degradation by human blood, implying that this oxytocin antagonist may have prolonged activity in vivo in humans.
Cystinyl Aminopeptidase
;
Female
;
Humans
;
Metabolism*
;
Obstetric Labor, Premature
;
Oxytocin*
;
Plasma*
;
Pregnancy
;
Pregnant Women*
;
Radioimmunoassay
;
Radioligand Assay
;
Uterine Contraction
;
Uterus
2.Effects of Glutathione on Cisplatin-Induced Cytotoxicity In Human Cervical Cancer Cell Lines.
Korean Journal of Obstetrics and Gynecology 2002;45(8):1289-1293
OBJECTIVE: The purpose of this study is to determine the effects of glutathione on cisplatin-induced cytotoxicity of human cervical carcinoma cell lines (SiHa: squamous cell carcinoma cell, CaSki: epidermoid metastatic carcinoma cell). METHODS: Human cervical carcinoma cells (SiHa, CaSki) were incubated with culture media (RPMI1640) in the presence of cisplatin and/or buthionine sulfoximine (BSO), as a inhibitor of gamma-glutamyl- cysteine synthetase, and/or glutathione (GSH) and/or 2-oxo 4-thiazolidine carboxylic acid (OTC). The viable cells were examined by using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and was determined by spectrophotometer at 570 nm. RESULTS: The incubation of cervical cells with cisplatin resulted in an decreasing cells viability by dose response. The MTT reduction rate were not different by BSO (5 mM) treatment in cervical cell lines. The viable cells were increased significantly by glutathione (5 mM) or OTC (5 mM) in cisplatin-treated cell lines. CONCLUSION: gamma-glutamylcysteine synthetase inhibitor had no effect on cisplatin toxicity. GSH and OTC had effect on cisplatin cytotoxicity. So, These result suggested that cervical cancer line cells were more susceptive to protective effects of glutathione and OTC than BSO on cisplatin induced-toxicity.
Buthionine Sulfoximine
;
Carcinoma, Squamous Cell
;
Cell Line*
;
Cisplatin
;
Culture Media
;
Cysteine
;
Glutathione*
;
Humans*
;
Ligases
;
Uterine Cervical Neoplasms*
3.Current Treatment Guidelines and Antihypertensive Therapy of Mild Chronic Hypertension During Pregnancy
Journal of the Korean Society of Maternal and Child Health 2023;27(3):140-147
Up to 5% of pregnant females experience chronic hypertension, which is linked to poor pregnancy outcomes, and along with hemorrhage, is considered one of the main causes of maternal morbidity and mortality. The combined occurrence of preeclampsia, cesarean sections, preterm birth, birth weight less than 2,500 g, neonatal unit admission, and perinatal death was higher in females with chronic hypertension. Pregnancy with systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg was considered to have mild-to-moderate chronic hypertension. Blood pressure management during pregnancy is a very important issue and is directly related to fetal growth and maternal health. Many studies have reported that antihypertensive therapy during pregnancy halves the incidence of severe hypertension in all types of hypertensive diseases. However, guidelines for optimal blood pressure management goals during pregnancy remain unclear. This is because the benefits to the mother from lowering blood pressure are uncertain, and there is a risk of fetal disorders due to the possibility of reduced uteroplacental blood flow. In light of a recently released CHAP (Chronic Hypertension and Pregnancy) randomized controlled trial, the purpose of this review was to provide a summary of the current recommendations for pregnant females with mild-to-moderate chronic hypertension.
4.Preeclampsia and aspirin
Obstetrics & Gynecology Science 2023;66(3):120-132
Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities. Aspirin is a non-selective non-steroidal anti-inflammatory drug that irreversibly inhibits cyclooxygenase enzymes involved in converting arachidonic acid to prostaglandins and thromboxane. Aspirin inhibits thromboxane A2 production via platelet aggregation, thereby increasing the prostacyclin/thromboxane A2 ratio and reducing platelet aggregation. Since the first case report of aspirin’s potential use during pregnancy was reported in 1978, many studies have attempted to confirm the effect of aspirin on PE, and the results have been controversial. However, this preventive strategy is generally accepted in clinical practice. As evidence for aspirin’s prevention of PE has been accumulating, a recent study investigated the effectiveness of aspirin at high doses of 150 mg, which is higher than before. However, there is an ongoing debate about how much aspirin should be used during pregnancy and when to start aspirin therapy. Guidelines for the use of prophylactic aspirin during pregnancy vary slightly among countries and groups. In this article, we review and summarize the evidence regarding the use of aspirin for PE prevention.
5.Clinical Usefulness of Double Combined Test (Cytology + Cervicography) for Cervical Cancer Screening.
Tae Gyu AHN ; Tae Jung KIM ; Sei Jun HAN
Korean Journal of Gynecologic Oncology and Colposcopy 2001;12(3):210-216
OBJECTIVE: For many years, the Papanicolaou smear has been used to detect pre-malignant and malignant disease of the cervix. Although the use of cytology in screening has reduced morbidity and mortality from invasive cervical cancer, there has been concerned about the low sensitivity of cervical cytology in detection of preclinical disease of the cervix. So cervicography is introduced. In order to find out the efficacy of cytology and cervicography in early diagnosis of cervical cancer, this study included 1028 patients who visited the Department of Obstetrics and Gynecology, Cho-sun University Hospital From December 1, 1995 to March 31, 1998. And we choosed 321 samples who underwent biopsies. METHODS: Women simultaneously underwent an exo and endo-cervical smear, and then two cervicography was obtained with applying 5% acetic acid. Because all of the subjects choosed in statistical analysis were examined by colposcopy or postoperative biopsies, the presence or abscence of disease was determined by the histologic findings. RESULTS: 1. The sensitivity and specificity of cytology was 55.4% and 86.6%. 2. The sensitivity and specificity of cervicography was 71.3% and 59.7%. 3. When cervicography and Papanicolaou smear were used conjointly, the sensitivity and specificity was 90.1% and 58.8%. 4. However the specificity of the combined test was lower than cytology alone, the sensitivity of the combined test was significantly higher. CONCLUSION: The double combined tests of Papanicolaou smear and Cervicography were very useful in the early diagnosis of cervical neoplasia.
Acetic Acid
;
Biopsy
;
Cervix Uteri
;
Colposcopy
;
Early Diagnosis
;
Female
;
Gynecology
;
Humans
;
Mass Screening*
;
Mortality
;
Obstetrics
;
Papanicolaou Test
;
Sensitivity and Specificity
;
Uterine Cervical Neoplasms*
6.The comparative evaluation of clinical screening in combined tests cytology (ThinPrep(R)), HPV DNA test (Hybrid capture(R) II),cervicography for uterine cervical cancer.
Tae Gyu AHN ; June Sun PARK ; Sei Jun HAN
Korean Journal of Gynecologic Oncology 2007;18(1):17-25
OBJECTIVE: Since the accuracy of Pap smear for cervical neoplasm has been questioned, a number of adjunctive tests have been developed. The purpose of this study was to evaluate which protocol is the most effective screening test among cervical cytology (ThinPrep(R)), HPV DNA test (Hybrid capture(R) II) and cervicography. METHODS: We chose 252 patients who were underwent the biopsy among 829 patients who visited our hospital for cervical cancer screening test. These 252 patients were engaged in this study simultaneously. They underwent triple combined test [cervical cytology (ThinPrep(R)), HPV DNA test (Hybrid capture(R) II), cervicography] and colposcopic-directed biopsy or biopsy on operation for diagnostic evaluation. RESULTS: The triple combined test showed a sensitivity of 96.0%, while double combined test [cervical cytology (ThinPrep(R))+cervicography] showed a sensitivity of 89.0%, the other double combined test [cervical cytology (ThinPrep(R))+HPV DNA test (Hybrid capture(R) II)] showed a sensitivity of 86.7%. Cervicography showed a specificity of 75.4% (highest among the single test), positive predictability of 89.8% (also highest). CONCLUSION: The sensitivity of cervical cytology was markedly improved by combination with HPV DNA test and cervicography. So the triple combined tests which improved the high false negative rate of cervical cytology may be a new effective method as a cervical cancer screening test, if the effectiveness could be confirmed by mass screening study.
Biopsy
;
DNA
;
Human Papillomavirus DNA Tests*
;
Humans
;
Mass Screening*
;
Sensitivity and Specificity
;
Uterine Cervical Neoplasms*
7.Prevalence of Benign Prostatic Hyperplasia in Jeong-Eup Area: Community-based Study.
Tae Gyu CHUNG ; Jinsoo CHUNG ; Moo Song LEE ; Hanjong AHN
Korean Journal of Urology 1999;40(1):52-58
PURPOSE: There is no consensus about a definition of benign prostatic hyperplasia, but there are various definitions based on a combination of clinical parameters used to describe the properties of BPH: symptoms of prostatism, increase of prostate volume, and bladder outlet obstruction. The prevalence of clinical BPH in Asian was believed to be lower than Caucasian. The lower urinary tract symptoms associated with BPH in Korea was reported by some authors and it was similar to the results of other studies in western countries. We report the prevalence of BPH in Korean men through a community-based study in Jeong-Eup county, Korea. MATERIALS AND METHODS: A total of 653 men aged 50 and over in Jeong-Eup area, Korea was randomly selected for determination of the prevalence of BPH. The definition of BPH in this study was combination of moderate(8-19) to severe(>19) I-PSS, enlargement of the prostate over 30gms on digital rectal examination by one board certified urologist, and decreased peak flow rate below 15ml/sec. Men with abnormal digital rectal examination(DRE) and elevated serum prostate specific antigen(PSA) above 3.5ng/ml were undergone sextant prostate biopsy to exclude the prostate cancer. RESULTS: I-PSS questionnaires were completed in 431 men and the response rate was 66.1%. Based on I-PSS, 162 men(37.6%) had moderate symptoms and 51 men(11.9%) severe symptoms. Of 213 men with moderate to severe symptoms, 35.7% had enlarged prostate by DRE, and 63.1% decreased flow rate. The prevalence of BPH by the definition in this study was 4.3% in their fifties, 13.2% in sixties and 16.3% in seventies and over eighty(overall, 11.1%). The population-adjusted prevalence of BPH in Korean men aged 50 and over was 8.7%. A good correlation was found between the total symptom score and the quality of life score that is included in the I-PSS. CONCLUSIONS: Men with moderate to severe I-PSS was 49.5%, which was similar to the results from other studies in Caucasian and Japanese. The prevalence of BPH in Korea by aforementioned definition was 8.7%, which seems to be lower than Caucasian. This results suggest that approximately 1,600,000 Korean men had moderate to severe urinary symptoms and 300,000 clinical BPH by the definition in this study.
Asian Continental Ancestry Group
;
Biopsy
;
Consensus
;
Digital Rectal Examination
;
Humans
;
Jeollabuk-do*
;
Korea
;
Lower Urinary Tract Symptoms
;
Male
;
Prevalence*
;
Prostate
;
Prostatic Hyperplasia*
;
Prostatic Neoplasms
;
Prostatism
;
Quality of Life
;
Surveys and Questionnaires
;
Urinary Bladder Neck Obstruction
8.Relation Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Epidemiologic Study in Jeong-Eup, Korea.
Taehyo KIM ; Tae Gyu CHUNG ; Tai Young AHN
Korean Journal of Andrology 1998;16(1):87-91
PURPOSE: Lower urinary tract symptoms and erectile dysfunction both have a profound impact on the quality of life elderly men, but there are few reports that would enable us to clearly elucidate the relation between them. We investigated the prevalence of erectile dysfunction and its correlation with the severity of lower urinary tract symptoms as judged by the International Prostatic Symptom Score (I-PSS). MATERIALS AND METHODS: The total sample was 855 men aged 30 years and older (653 aged over 50) in 31 randomly selected areas of Jeong-Eup, Korea. Two questionnaires were sent. The first, on sexual activities, was based on DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th ed.) and was composed of several questions on the frequency of sexual intercourse, erectile ability, and the degree of any erectile dysfunction. The second, for men over 50 years of age, was the I-PSS. We analyzed the results with multivariate logistic analysis using an SAS program running on a personal computer. RESULTS: The response rate was 71.3% (466/653), and data sexual activities and I-PSS from 304 men were suitable for analysis. The prevalence of erectile dysfunction, defined as inability to achieve an erection sufficient for penetration, was 58.9% (179/304), and increased with age: 37.2% in men in their 50s, 69.2% in men in their 60s, 83.3% in men in their 70s, ans 100% in men over age: 37.2% in men in their 50s, 69.2% in men in their 60s, 83.3% in men in their 70s, and 100% in men over age 80 (p = 0.001). According to the intensity of lower urinary tract symptoms - mild (0-7), moderate (8-19), and severe (20-35) - the prevalence of erectile dysfunction was 46.6% (75/161), 68.8% (75.109), and 85.3% (29.34), respectively, and the prevalence of complete erectile dysfunction was 8.7% (14.161), 20.2% (22.109), and 47.1% (16.34), respectively. After adjustment for age, there was a statistically significant correlation between the severity of lower urinary tract symptoms and erectile dysfunction with the odds ratios being 2.395 and 4.125 in the moderately and severely symptomatic groups. CONCLUSIONS: There was a significant correlation between the presence of lower urinary tract symptoms and erectile dysfunction. We suggest that these two conditions are closed related by pathophysiologic mechanism, although clinical and basic research should be advanced to clarify the relation between them.
Aged
;
Aging
;
Coitus
;
Diagnostic and Statistical Manual of Mental Disorders
;
Epidemiologic Studies*
;
Erectile Dysfunction*
;
Humans
;
Jeollabuk-do*
;
Korea*
;
Lower Urinary Tract Symptoms*
;
Male
;
Mental Disorders
;
Microcomputers
;
Odds Ratio
;
Prevalence
;
Quality of Life
;
Surveys and Questionnaires
;
Running
;
Sexual Behavior
9.Relation Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Epidemiologic Study in Jeong-Eup, Korea.
Taehyo KIM ; Tae Gyu CHUNG ; Tai Young AHN
Korean Journal of Andrology 1998;16(1):87-91
PURPOSE: Lower urinary tract symptoms and erectile dysfunction both have a profound impact on the quality of life elderly men, but there are few reports that would enable us to clearly elucidate the relation between them. We investigated the prevalence of erectile dysfunction and its correlation with the severity of lower urinary tract symptoms as judged by the International Prostatic Symptom Score (I-PSS). MATERIALS AND METHODS: The total sample was 855 men aged 30 years and older (653 aged over 50) in 31 randomly selected areas of Jeong-Eup, Korea. Two questionnaires were sent. The first, on sexual activities, was based on DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th ed.) and was composed of several questions on the frequency of sexual intercourse, erectile ability, and the degree of any erectile dysfunction. The second, for men over 50 years of age, was the I-PSS. We analyzed the results with multivariate logistic analysis using an SAS program running on a personal computer. RESULTS: The response rate was 71.3% (466/653), and data sexual activities and I-PSS from 304 men were suitable for analysis. The prevalence of erectile dysfunction, defined as inability to achieve an erection sufficient for penetration, was 58.9% (179/304), and increased with age: 37.2% in men in their 50s, 69.2% in men in their 60s, 83.3% in men in their 70s, ans 100% in men over age: 37.2% in men in their 50s, 69.2% in men in their 60s, 83.3% in men in their 70s, and 100% in men over age 80 (p = 0.001). According to the intensity of lower urinary tract symptoms - mild (0-7), moderate (8-19), and severe (20-35) - the prevalence of erectile dysfunction was 46.6% (75/161), 68.8% (75.109), and 85.3% (29.34), respectively, and the prevalence of complete erectile dysfunction was 8.7% (14.161), 20.2% (22.109), and 47.1% (16.34), respectively. After adjustment for age, there was a statistically significant correlation between the severity of lower urinary tract symptoms and erectile dysfunction with the odds ratios being 2.395 and 4.125 in the moderately and severely symptomatic groups. CONCLUSIONS: There was a significant correlation between the presence of lower urinary tract symptoms and erectile dysfunction. We suggest that these two conditions are closed related by pathophysiologic mechanism, although clinical and basic research should be advanced to clarify the relation between them.
Aged
;
Aging
;
Coitus
;
Diagnostic and Statistical Manual of Mental Disorders
;
Epidemiologic Studies*
;
Erectile Dysfunction*
;
Humans
;
Jeollabuk-do*
;
Korea*
;
Lower Urinary Tract Symptoms*
;
Male
;
Mental Disorders
;
Microcomputers
;
Odds Ratio
;
Prevalence
;
Quality of Life
;
Surveys and Questionnaires
;
Running
;
Sexual Behavior
10.A Case of Endometriosis in the Abdominal Subcutaneous Tissue.
Hyun Ju MOON ; Tae Gyu AHN ; Kyung LEE ; Hyoung Gyun ROH ; Sang Joon CHOI ; Chang Hoon SONG ; Hyuk JUNG
Korean Journal of Obstetrics and Gynecology 1999;42(3):641-645
the ineidence of abdominal subcutaneous endometriosis is quite rare we have experienced one case of subcutaneous endometriosis. The typical clinical bistory and local findings of endometriasis enabk us to make the conect diagnosis. the treatment of choice is complete surgical excision of endometrial tissue and post operative medical therapy. This case was reported with a brief review of the comcemed literatures.
Diagnosis
;
Endometriosis*
;
Female
;
Subcutaneous Tissue*